IL62039A - 2-(2-(1,4-benzodioxanyl))-2-imidazoline and non-toxic salts thereof,processes for the preparation thereof and pharmaceutical compositions containing them - Google Patents

2-(2-(1,4-benzodioxanyl))-2-imidazoline and non-toxic salts thereof,processes for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
IL62039A
IL62039A IL62039A IL6203981A IL62039A IL 62039 A IL62039 A IL 62039A IL 62039 A IL62039 A IL 62039A IL 6203981 A IL6203981 A IL 6203981A IL 62039 A IL62039 A IL 62039A
Authority
IL
Israel
Prior art keywords
benzodioxanyl
imidazoline
processes
preparation
pharmaceutical compositions
Prior art date
Application number
IL62039A
Other languages
English (en)
Other versions
IL62039A0 (en
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of IL62039A0 publication Critical patent/IL62039A0/xx
Publication of IL62039A publication Critical patent/IL62039A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL62039A 1980-02-04 1981-02-01 2-(2-(1,4-benzodioxanyl))-2-imidazoline and non-toxic salts thereof,processes for the preparation thereof and pharmaceutical compositions containing them IL62039A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8003636 1980-02-04

Publications (2)

Publication Number Publication Date
IL62039A0 IL62039A0 (en) 1981-03-31
IL62039A true IL62039A (en) 1985-01-31

Family

ID=10511105

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62039A IL62039A (en) 1980-02-04 1981-02-01 2-(2-(1,4-benzodioxanyl))-2-imidazoline and non-toxic salts thereof,processes for the preparation thereof and pharmaceutical compositions containing them

Country Status (26)

Country Link
US (1) US4818764A (hu)
EP (1) EP0033655B1 (hu)
JP (1) JPS56122378A (hu)
AR (1) AR225794A1 (hu)
AT (1) ATE7228T1 (hu)
AU (1) AU535320B2 (hu)
CA (1) CA1156241A (hu)
CS (1) CS254956B2 (hu)
DD (1) DD155991A5 (hu)
DE (1) DE3163256D1 (hu)
DK (1) DK160092C (hu)
ES (1) ES8202553A1 (hu)
FI (1) FI67543C (hu)
GB (1) GB2068376B (hu)
GR (1) GR73853B (hu)
HU (1) HU187295B (hu)
IE (1) IE51736B1 (hu)
IL (1) IL62039A (hu)
NO (1) NO154882C (hu)
NZ (1) NZ196162A (hu)
PH (1) PH16249A (hu)
PL (1) PL128368B1 (hu)
PT (1) PT72435B (hu)
SU (1) SU1128837A3 (hu)
ZA (1) ZA81666B (hu)
ZW (1) ZW2381A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions
FR2527208B1 (fr) * 1982-05-19 1985-07-19 Inst Nat Sante Rech Med Isomeres optiques de la (benzodioxanne-1,4 yl-2)-2d-2 imidazoline, leur preparation et leur application en therapeutique
EP0115142B1 (en) * 1982-12-23 1986-11-05 Ici Americas Inc. Chroman compounds
US4634714A (en) * 1983-12-01 1987-01-06 American Home Products Corporation Inhibition of prolactin release by a benzodioxinylimidazoline derivative
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
US5240930A (en) * 1987-09-02 1993-08-31 National Research Development Corporation Pharmaceutical compositions for treatment of depression and low blood pressure
GB8720600D0 (en) * 1987-09-02 1987-10-07 Saad Al Damluji Pharmaceutical compositions
FR2698789B1 (fr) * 1992-12-07 1995-03-03 Pf Medicament Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
FR2700113B1 (fr) * 1993-01-07 1995-03-24 Pf Medicament Utilisation de l'Idazoxan et ses dérivés pour la fabrication de médicaments destinés au traitement des maladies neurodégénératives et en particulier l'évolution de la maladie d'Alzheimer.
US5574059A (en) * 1995-10-27 1996-11-12 Cornell Research Foundation, Inc. Treating disorders mediated by vascular smooth muscle cell proliferation
FR2795727B1 (fr) * 1999-06-29 2001-09-21 Pf Medicament Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
FR2801786B1 (fr) * 1999-12-01 2002-03-01 Fabre Pierre Cosmetique Nouvelles compositions topiques a base d'idazoxan et de cafeine ou de ses derives solubles et leur utilisation comme amincissant et/ou dans le traitement de la cellulite
US20030022814A1 (en) * 2000-02-29 2003-01-30 Reines Scott A Method for treating or preventing depression
US7595335B2 (en) * 2003-10-28 2009-09-29 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US8476307B2 (en) * 2003-10-28 2013-07-02 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
FR2861299B1 (fr) * 2003-10-28 2006-01-27 Pf Medicament Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
WO2023159145A1 (en) * 2022-02-16 2023-08-24 Terran Biosciences, Inc. Deuterated idazoxan and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2641601A (en) * 1950-11-24 1953-06-09 Hoffmann La Roche Furans and method of preparation
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
JPS5276346A (en) * 1975-12-22 1977-06-27 Sumitomo Bakelite Co Ltd Epoxy resin adhesive composition
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
US4302469A (en) * 1980-09-10 1981-11-24 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
US4315021A (en) * 1980-12-03 1982-02-09 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles
US4301171A (en) * 1980-12-03 1981-11-17 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)benzimidazoles useful as anti-depressants
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Also Published As

Publication number Publication date
ES499034A0 (es) 1982-02-01
IE51736B1 (en) 1987-03-18
EP0033655A2 (en) 1981-08-12
CS254956B2 (en) 1988-02-15
PH16249A (en) 1983-08-16
ZW2381A1 (en) 1981-06-24
CS73881A2 (en) 1987-07-16
DK160092C (da) 1991-06-24
ATE7228T1 (de) 1984-05-15
NO154882B (no) 1986-09-29
AU535320B2 (en) 1984-03-15
ZA81666B (en) 1982-04-28
FI810288L (fi) 1981-08-05
GR73853B (hu) 1984-05-07
CA1156241A (en) 1983-11-01
HU187295B (en) 1985-12-28
NO810351L (no) 1981-08-05
AR225794A1 (es) 1982-04-30
GB2068376B (en) 1983-06-22
DK160092B (da) 1991-01-28
DK45081A (da) 1981-08-05
AU6675881A (en) 1981-08-13
US4818764A (en) 1989-04-04
PL128368B1 (en) 1984-01-31
GB2068376A (en) 1981-08-12
ES8202553A1 (es) 1982-02-01
PT72435B (pt) 1982-01-29
EP0033655A3 (en) 1981-11-25
FI67543C (fi) 1985-04-10
PL229488A1 (hu) 1981-10-16
DE3163256D1 (en) 1984-05-30
NO154882C (no) 1987-01-07
IL62039A0 (en) 1981-03-31
PT72435A (en) 1981-03-01
JPH0231077B2 (hu) 1990-07-11
JPS56122378A (en) 1981-09-25
FI67543B (fi) 1984-12-31
EP0033655B1 (en) 1984-04-25
DD155991A5 (de) 1982-07-21
IE810199L (en) 1981-08-04
SU1128837A3 (ru) 1984-12-07
NZ196162A (en) 1983-06-17

Similar Documents

Publication Publication Date Title
DE3173861D1 (en) 2-(trichloro-methyl-phenyl)-4-halogen-oxazole derivatives, process for preparing them and radiation-sensitive compositions containing them
IL62082A0 (en) -lactam derivatives,process for the preparation thereof and pharmaceutical compositions containing them
IL62039A (en) 2-(2-(1,4-benzodioxanyl))-2-imidazoline and non-toxic salts thereof,processes for the preparation thereof and pharmaceutical compositions containing them
PT74923A (en) Process for preparing substituted 1,2-diaminocyclobutene-3,4-diones and pharmaceutical compositions containing the same
IL57020A (en) Carbazolyl-(4)-oxypropanolamine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PT75689A (en) Process for preparing novel phenyl-substituted sulfonamides and herbicide compositions containing the same
DE3276110D1 (en) Amide derivatives, processes for preparing them, their use as fungicides and pesticidal compositions containing them
PT73355B (en) Process for preparing herbicidal sulfonamides and herbicidal compositions containing the same
IL58478A0 (en) Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines
IL70488A (en) 7(2-(difluoromethylthio)-acetylamino)-7-methoxy-3-tetrazolyl-thiomethyl-1-dethia-1-oxacephalosporins,processes for the preparation thereof and pharmaceutical and veterinary compositions containing the same
DE3167664D1 (en) Pyrazoloindazole derivatives, process for preparing the same, and pharmaceutical composition containing the same
DE3262919D1 (en) Imidazoline derivatives, process for the preparation thereof, pharmaceutical compositions containing them and their use
IL57213A (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them
IL70434A0 (en) New benzylcarbamoylpyridine derivatives,processes for the preparation thereof and herbicidal compositions containing the same
IL64416A (en) N-cyclopropyloxyphenyl-n'-benzoylurea derivatives,process for the preparation thereof and insecticidal compositions containing them
PH16945A (en) Substituted triphenyl thiazole compounds,their pharmaceutical compositions and their use
PH17057A (en) Kijanimicin and salts thereof,pharmaceutical compositions containing same and process of preparring same
IL67403A0 (en) Azolyl-pentene derivatives,process for their preparation and biocidal compositions containing the same
PT74400A (en) Process for the preparation of 17,18-dehydro-apovincaminol-3', 4',5'-trimethoxy-benzoate and of pharmaceutical compositions containing them
IL68425A0 (en) 1,2,4-triazol-1-yl-propionitrile derivatives,processes for the preparation thereof and biocidal compositions containing the same
ZA82773B (en) Substituted 2-(anilinomethyl)-2-imidazoline derivatives,processes for producing them,compositions containing these derivatives,and the use thereof for combating pests
DE3264578D1 (en) Thio-substituted-1,3,5-triazine-diamines and -triamines useful as prevulcanization inhibitors
ZA815988B (en) Aminoacid derivatives,a process for their preparation,agents containing these compounds,and the use thereof
ZW2582A1 (en) Substituted 2-(anilinomethyl)-2-imidazoline derivatives processes for producing them compositions containing these derivatives and the use thereof for combating pests
IL65146A0 (en) 4-substituted mercapto-2-oxo-1-azetidinesulfonic acid salts,pharmaceutical compositions containing them and methods for the use thereof

Legal Events

Date Code Title Description
KB Patent renewed
EXP Patent expired